Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12
Glioblastoma is the most common and aggressive malignant brain tumor and has limited treatment options. Hence, innovative approaches are urgently needed. Oncolytic virus therapy is emerging as a promising modality for cancer treatment due to its tumor-specific targeting and immune-stimulatory proper...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-06-01
|
| Col·lecció: | Molecular Therapy: Oncology |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2950329924000419 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|